Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 9 October 2009:
Vol. 326. no. 5950, pp. 218 - 220
DOI: 10.1126/science.326_218
Prev | Table of Contents | Next

News Focus

Cancer Research:

Looking for a Target On Every Tumor

Jocelyn Kaiser

A handful of major U.S. cancer centers are laying plans to analyze the tumors of every lung cancer patient who comes in the door and check for an array of mutations. The aim is to match patients with a drug that goes after the tumor's genetic weak spot. Proponents hope that comprehensive tumor genetic testing will soon become a standard part of a patient's medical record. The grim reality, however, is that even when a match is found, the new targeted drugs have mainly slowed tumors, not stopped them in advanced lung cancer.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)